147 related articles for article (PubMed ID: 10758273)
1. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
Adler M; Capacio B; Deshpande SS
Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273
[TBL] [Abstract][Full Text] [Related]
2. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
Adler M; Macdonald DA; Sellin LC; Parker GW
Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
[TBL] [Abstract][Full Text] [Related]
3. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
[TBL] [Abstract][Full Text] [Related]
5. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
Bradford AB; Machamer JB; Russo TM; McNutt PM
Toxicol Appl Pharmacol; 2018 Feb; 341():77-86. PubMed ID: 29366638
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations.
Adler M; Scovill J; Parker G; Lebeda FJ; Piotrowski J; Deshpande SS
Toxicon; 1995 Apr; 33(4):527-37. PubMed ID: 7570638
[TBL] [Abstract][Full Text] [Related]
7. Inotropic effects of the K+ channel blocker 3,4-diaminopyridine: differential responses of rat soleus and extensor digitorum longus.
van Lunteren E; Pollarine J; Moyer M
IEEE Trans Neural Syst Rehabil Eng; 2006 Dec; 14(4):419-26. PubMed ID: 17190034
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic treatment of botulism with a clinically approved small molecule.
Vazquez-Cintron E; Machamer J; Ondeck C; Pagarigan K; Winner B; Bodner P; Kelly K; Pennington MR; McNutt P
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996484
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Thyagarajan B; Potian JG; Garcia CC; Hognason K; Capková K; Moe ST; Jacobson AR; Janda KD; McArdle JJ
Neuropharmacology; 2010 Jun; 58(8):1189-98. PubMed ID: 20211192
[TBL] [Abstract][Full Text] [Related]
10. Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations.
Adler M; Deshpande SS; Apland JP; Murray B; Borrell A
Neurochem Int; 2012 Nov; 61(6):866-73. PubMed ID: 22841859
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction.
Kauffman JA; Way JF; Siegel LS; Sellin LC
Toxicol Appl Pharmacol; 1985 Jun; 79(2):211-7. PubMed ID: 2988154
[TBL] [Abstract][Full Text] [Related]
12. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM
Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174
[TBL] [Abstract][Full Text] [Related]
13. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
Fujikawa R; Muroi Y; Unno T; Ishii T
J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
[TBL] [Abstract][Full Text] [Related]
14. Improvement of diaphragm and limb muscle isotonic contractile performance by K+ channel blockade.
van Lunteren E; Pollarine J
J Neuroeng Rehabil; 2010 Jan; 7():1. PubMed ID: 20064261
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine.
Lundh H; Leander S; Thesleff S
J Neurol Sci; 1977 May; 32(1):29-43. PubMed ID: 194021
[TBL] [Abstract][Full Text] [Related]
16. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
Simpson LL
Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
[TBL] [Abstract][Full Text] [Related]
17. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.
Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265
[TBL] [Abstract][Full Text] [Related]
19. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
20. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]